HSR&D Research Career Scientist Award

药物使用障碍 (SUD) 在退伍军人健康管理局 (VHA) 患者中很常见， 与退伍军人面临的一些最紧迫的问题密切相关，包括服药过量、自杀风险 和无家可归。 VHA 在提供高质量 SUD 治疗方面处于全国领先地位 以及建立证据库，为患有 SUD 的退伍军人提供信息并改善其护理。 然而，关键差距仍然存在，特别是对于同时患有 SUD 和精神和/或疾病的退伍军人来说 医疗条件。尽管如此，显然有潜力扩大实质性的积极影响—— 通过改善行为健康治疗的可及性并整合这些治疗，在 VA 内提供导向服务 成瘾治疗服务。马克·伊尔根博士开发了一个研究组合，重点关注 通过开展以退伍军人为中心的医疗服务，定制 SUD 治疗方案以解决患者合并症 对成瘾的研究。这项工作的两个主要主题目标是： 目标 1：改善治疗 减少同时发生 SUD 和慢性疼痛的退伍军人的不良事件风险； 目标 2：降低持有 SUD 的退伍军人的自杀风险。这两个主题领域直接 与积极的治疗结果相关，并减少不良事件的可能性，其中 持有 SUD 的退伍军人。伊尔根博士对这些领域的贡献通过他的资助研究得到了证明 在 VA 卫生服务研究与开发 (HSR&D) 的支持下， 国防部和国家药物滥用研究所，以及超过 165 个经过同行评审的科学机构 出版物。 Ilgen 博士积极指导 VA 内的九名早期职业调查员和/或实习生 并曾在安娜堡弗吉尼亚州创新中心 (COIN) 担任重要行政职务， 领导团队成员和指导核心的共同领导者。鉴于他的积极和富有成效 研究组合，以及他对指导同事开发 VA 的承诺 在研究生涯中，伊尔根博士是卫生服务研究职业科学家奖的有力候选人。 拟议的研究职业科学家奖将支持他继续研究，并扩大 在指导和培训下一代 HSR&D 研究人员方面发挥作用。该研究组合有 有可能解决 VHA 中一些最关键和最令人烦恼的行为健康相关优先事项 并改善对 VHA 内接受治疗的一些最具挑战性和风险最高的退伍军人的护理 系统。

Substance Use Disorders (SUDs) are common in Veterans Health Administration (VHA) patients and are closely linked to some of the most pressing problems facing Veterans including overdose, suicide risk and homelessness. The VHA is a national leader in providing access to high-quality SUD treatment as well as the development of an evidence-base to inform and improve care for Veterans with SUDs. However, key gaps remain, particularly for Veterans who have co-occurring SUDs and psychiatric and/or medical conditions. Nonetheless, there is the clear potential to expand the positive impact of substance- oriented services within the VA by improving access to behavioral health treatments and integrating these services into addictions treatment. Mark Ilgen, Ph.D. has developed a research portfolio focused on tailoring SUD treatment to address patient comorbidity by conducting Veteran-centric health services research on addiction. The two primary thematic aims of this work are: Aim 1: to improve treatment outcomes and reduce risk of adverse events among Veterans with co-occurring SUDs and chronic pain; and, Aim 2: to decrease the risk of suicide among Veterans with SUDs. These two thematic areas directly relate to positive treatment outcomes, as well as reducing the likelihood of adverse events, among Veterans with SUDs. Dr. Ilgen's contributions to these areas are evidenced by his grant-funded research with support from the VA Health Services Research and Development (HSR&D), the Department of Defense and the National Institute on Drug Abuse, in addition to over 165 peer-reviewed scientific publications. Dr. Ilgen has actively mentored nine early career investigators and/or trainees within the VA and has held key administrative positions within the Ann Arbor VA Center of Innovation (COIN), as a member of the leadership team and the co-lead of the Mentorship Core. Given his active and productive research portfolio, as well as his demonstrated commitment to mentoring colleagues in developing VA research careers, Dr. Ilgen is a strong candidate for a Health Services Research Career Scientist Award. The proposed Research Career Scientist Award will support his continued research, as well an expanded role in mentorship and training of the next generation of HSR&D researchers. This research portfolio has the potential to address some of the most-critical and vexing behavioral health-related priorities in VHA and improve care for some of the most challenging and highest-risk Veterans treated within the VHA system.